Ferumoxytol is a licensed carbohydrate-coated, superparamagnetic iron oxide nanoparticle indicated in the treatment of anaemia. We show that, in contrast to other agents, it predominantly reduces T2, is confined to the blood pool for >1 hour post administration, and therefore could improve the efficiency of saturation pulses that aim to remove the 2,3-diphosphoglycerate signal from blood. This proof-of-principle study shows that Ferumoxytol could enable inorganic phosphate detection in vivo, and hence the determination of pH.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords